Inovio Pharmaceuticals, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Inovio Pharmaceuticals, Inc. (INO) is 116.04M

According to Inovio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 116.04M. This represents a change of 32.77% compared to the average of 87.40M of the last 4 quarters.

Inovio Pharmaceuticals, Inc. (INO) Historical Enterprise Value (quarterly & annually)

How has INO Enterprise Value performed in the past?

The mean historical Enterprise Value of Inovio Pharmaceuticals, Inc. over the last ten years is 426.96M. The current 116.04M Enterprise Value has changed -72.82% with respect to the historical average. Over the past ten years (40 quarters), INO's Enterprise Value was at its highest in in the June 2020 quarter at 4.08B. The Enterprise Value was at its lowest in in the December 2024 quarter at 5.45M.

Inovio Pharmaceuticals, Inc. (INO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Inovio Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inovio Pharmaceuticals, Inc. (INO) Average Enterprise Value

How has INO Enterprise Value performed in the past?

The current Enterprise Value of Inovio Pharmaceuticals, Inc. (INO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Inovio Pharmaceuticals, Inc. (INO) Enterprise Value vs. Peers

How is INO’s Enterprise Value compared to its peers?

Inovio Pharmaceuticals, Inc.’s Enterprise Value is greater than Acumen Pharmaceuticals, Inc. (-8417400.00), less than Opus Genetics, Inc. (251.03M), less than Agenus Inc. (316.43M), greater than Seer, Inc. (89.89M), greater than Spero Therapeutics, Inc. (11.83M), less than Fate Therapeutics, Inc. (280.44M), greater than Seres Therapeutics, Inc. (59.94M), greater than VistaGen Therapeutics, Inc. (-8694991.00), less than Alector, Inc. (211.23M), greater than Actuate Therapeutics Inc (4.03M),

Build a custom stock screener for Inovio Pharmaceuticals, Inc. (INO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inovio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inovio Pharmaceuticals, Inc. (INO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inovio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.